LifeStance Health Group, Inc.
LFST
$4.08
$0.1754.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 103.36% | 84.18% | 90.33% | 48.82% | 38.39% |
| Total Depreciation and Amortization | -39.04% | -33.96% | -22.97% | -4.76% | 18.33% |
| Total Amortization of Deferred Charges | -40.80% | -21.02% | -18.60% | -20.30% | -22.77% |
| Total Other Non-Cash Items | 3.42% | 176.38% | -19.91% | -21.92% | -14.49% |
| Change in Net Operating Assets | 9.54% | -15.96% | 21.52% | 170.67% | -97.83% |
| Cash from Operations | 85.84% | 271.04% | 189.62% | 10,252.07% | -176.78% |
| Capital Expenditure | -40.44% | 44.80% | 48.44% | 55.88% | 33.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -40.44% | 44.80% | 48.44% | 55.88% | 81.47% |
| Total Debt Issued | -- | 778.73% | -- | -- | -- |
| Total Debt Repaid | -148.02% | -44,168.10% | -12.81% | -24.70% | -24.74% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -260.82% | -7.74% | 35.60% | 60.48% |
| Cash from Financing | -310.32% | -113.16% | -9.52% | -106.14% | 50.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.11% | 43.45% | 142.29% | 231.69% | 27.16% |